X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2022/02/09/2382305/0/en/Active-Biotech-Year-End-Report-2021.html
https://www.globenewswire.com/news-release/2021/12/10/2349825/0/en/First-subject-dosed-in-phase-I-clinical-study-with-eye-drop-formulation-of-laquinimod.html
https://www.activebiotech.com/en/active-biotech-enters-into-a-manufacturing-agreement-with-famar-health-care-services-for-new-formulation-of-laquinimod/
http://www.pharmatimes.com/news/teva_drops_development_of_laquinimod_1251494
https://www.biospectrumasia.com/news/26/11650/active-biotech-regains-rights-of-laquinimod-from-teva.html
https://www.fiercebiotech.com/biotech/teva-finally-dumps-laquinimod-ending-failure-riddled-saga
https://endpts.com/tevas-one-time-blockbuster-to-be-and-now-recurring-embarrassment-laquinimod-fails-yet-again-this-time-for-huntingtons/
Market Place
Share 
